MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits

Cell Proliferation

Volumn 44, Issue 1, 2011, Pages 59-66

  Lee, J E ^a   Hong, E J ^a   Nam, H Y ^a   Kim, J W ^a   Han, B G ^a   Jeon, J P ^a  

^a Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MICROARRAY ANALYSIS; UPREGULATION;

AMINO ACID MOTIFS; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HERPESVIRUS 4, HUMAN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINEAR MODELS; LYMPHOCYTES; MICRORNAS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASE C; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED;

HUMAN HERPESVIRUS 4;

EID: 78650690080     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00717.x     Document Type: Article

References (38)

1. Hu VW, Sarachana T, Kim KS, Nguyen A, Kulkarni S, Steinberg ME et al. (2009) Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2, 78-97.
2. Valle M, Plon SE, Rabin KR (2009) Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia. Leuk. Res. 33, 336-339.
3. Martin MV, Rollins B, Sequeira PA, Mesen A, Byerley W, Stein R et al. (2009) Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation. BMC Med. Genomics 2, 62.
4. Bleibel WK, Duan S, Huang RS, Kistner EO, Shukla SJ, Shukla X et al. (2009) Identification of genomic regions contributing to etoposide-induced cytotoxicity. Hum. Genet. 125, 173-180.
5. Zhang W, Huang RS, Dolan ME (2008) Integrating epigenomics into pharmacogenomic studies. Pharmacogenomics Pers. Med. 1, 7-14.
6. Baik SY, Yun HS, Lee HJ, Lee MH, Jung SE, Kim JW et al. (2007) Identification of stathmin 1 expression induced by Epstein-Barr virus in human B lymphocytes. Cell Prolif. 40, 268-281.
7. Jeon JP, Shim SM, Nam HY, Baik SY, Kim JW, Han BG (2007) Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines. Cancer Genet. Cytogenet. 173, 122-130.
8. Lee JE, Nam HY, Shim SM, Bae GR, Han BG, Jeon JP (2010) Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance. Cell Prolif. 43, 378-384.
9. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X et al. (2008) Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 82, 1946-1958.
10. Hannon GJ (2002) RNA interference. Nature 418, 244-251.
11. Cullen BR (2004) Transcription and processing of human microRNA precursors. Mol. Cell 16, 861-865.
12. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294, 853-858.
13. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
14. Stefani G, Slack FJ (2008) Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 9, 219-230.
15. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65, 9628-9632.
16. Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1-12.
17. Lee YS, Dutta A (2006) MicroRNAs: small but potent oncogenes or tumor suppressors. Curr. Opin. Investig. Drugs 7, 560-564.
18. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A (2004) High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39, 167-169.
19. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99, 15524-15529.
20. Yao Q, Xu H, Zhang QQ, Zhou H, Qu LH (2009) MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem. Biophys. Res. Commun. 388, 539-542.
21. Jeon JP, Nam HY, Shim SM, Han BG (2009) Sustained viral activity of Epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines. Mol. Cells 27, 143-148.
22. Fan JB, Yeakley JM, Bibikova M, Chudin E, Wickham E, Chen J et al. (2004) A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res. 14, 878-885.
23. Cameron JE, Fewell C, Yin Q, McBride J, Wang X, Lin Z et al. (2008) Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 382, 257-266.
24. Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z et al. (2008) MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82, 5295-5306.
25. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI (2008) Mature miR-184 as potential Oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 14, 2588-2592.
26. Nagayama K, Kohno T, Sato M, Arai Y, Minna JD, Yokota J (2007) Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosomes Cancer 46, 1000-1010.
27. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH et al. (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin. Cancer Res. 14, 2690-2695.
28. Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan F, Jentzmik K et al. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 126, 1166-1176.
29. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K et al. (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 125, 345-352.
30. Gonzalez-Sancho JM, Garcia V, Bonilla F, Munoz A (2003) Thyroid hormone receptors/THR genes in human cancer. Cancer Lett. 192, 121-132.
31. Gamerdinger M, Hajieva P, Kaya AM, Wolfrum U, Hartl FV, Behl C (2009) Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 28, 889-901.
32. Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sanudo A et al. (2009) Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol. Oncol. [Epub ahead of print].
33. Moeslein FM, Myers MP, Landreth GE (1999) The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the tyrosine phosphatase, PTP-1B. J. Biol. Chem. 274, 26697-26704.
34. Radich JP, Dai H, Mao M, Oehler V, Schelter J, Druker B et al. (2006) Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc. Natl. Acad. Sci. USA 103, 2794-2799.
35. Fairfax BP, Vannberg FO, Radhakrishnan J, Hakonarson H, Keating BJ, Hill AV et al. (2010) An integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6. Hum. Mol. Genet. 19, 720-730.
36. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M et al. (2003) Natural variation in human gene expression assessed in lymphoblastoid cells. Nat. Genet. 33, 422-425.
37. Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout SD et al. (2009) Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS One 4, e7037.
38. Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H et al. (2005) Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int. 25, 760-771.